Newsletter | January 7, 2021

01.07.21 -- Biosimilars In 2021 And Beyond

Featured Editorial
Industry Insights
Developing A Closed Connected Single-Use mAb Purification Process

This article provides an overview of a successfully designed closed and physically connected monoclonal antibody (mAb) process at the pilot scale with single-use components.

Standing Out In The Crowded Biopharma CDMO Market

This presentation addresses what motivates drug innovators to outsource, who is involved in service provider selection, and which attributes have the greatest influence on CDMO selection.

News Headlines